Metabolomic Profile in HFpEF vs HFrEF Patients.
Saved in:
| Title: | Metabolomic Profile in HFpEF vs HFrEF Patients. |
|---|---|
| Authors: | Hage C; Karolinska Institutet, Department of Medicine, Cardiology unit, Stockholm, Sweden. Electronic address: camilla.hage@sll.se., Löfgren L; Translational Science and Experimental Medicine; Research and early Development, Cardiovascular, Renal and Metabolism, Biopharmaceutical R&D, AstraZeneca, Gothenburg, Sweden., Michopoulos F; Bioscience, Early Oncology R&D, AstraZenenca, Cambridge, UK., Nilsson R; Translational Science and Experimental Medicine; Research and early Development, Cardiovascular, Renal and Metabolism, Biopharmaceutical R&D, AstraZeneca, Gothenburg, Sweden., Davidsson P; Translational Science and Experimental Medicine; Research and early Development, Cardiovascular, Renal and Metabolism, Biopharmaceutical R&D, AstraZeneca, Gothenburg, Sweden., Kumar C; Translational Science and Experimental Medicine; Research and early Development, Cardiovascular, Renal and Metabolism, Biopharmaceutical R&D, AstraZeneca, Gothenburg, Sweden., Ekström M; Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine Stockholm, Sweden., Eriksson MJ; Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden., Lyngå P; Karolinska Institutet, Department of Clinical Science and Education, Sodersjukhuset, Stockholm, Sweden., Persson B; Uppsala University, Department of Cell and Molecular Biology, Science for Life Laboratory, Uppsala, Sweden., Wallén H; Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine Stockholm, Sweden., Gan LM; Early Clinical Development, Research and early Development, Cardiovascular, Renal and Metabolism, Biopharmaceutical R&D, AstraZeneca, Gothenburg, Sweden., Persson H; Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine Stockholm, Sweden., Linde C; Karolinska Institutet, Department of Medicine, Cardiology unit, Stockholm, Sweden. |
| Source: | Journal of cardiac failure [J Card Fail] 2020 Dec; Vol. 26 (12), pp. 1050-1059. Date of Electronic Publication: 2020 Aug 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Churchill Livingstone Country of Publication: United States NLM ID: 9442138 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8414 (Electronic) Linking ISSN: 10719164 NLM ISO Abbreviation: J Card Fail Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32750486 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Metabolomic Profile in HFpEF vs HFrEF Patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hage+C%22">Hage C</searchLink>; Karolinska Institutet, Department of Medicine, Cardiology unit, Stockholm, Sweden. Electronic address: camilla.hage@sll.se.<br /><searchLink fieldCode="AU" term="%22Löfgren+L%22">Löfgren L</searchLink>; Translational Science and Experimental Medicine; Research and early Development, Cardiovascular, Renal and Metabolism, Biopharmaceutical R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Michopoulos+F%22">Michopoulos F</searchLink>; Bioscience, Early Oncology R&D, AstraZenenca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Nilsson+R%22">Nilsson R</searchLink>; Translational Science and Experimental Medicine; Research and early Development, Cardiovascular, Renal and Metabolism, Biopharmaceutical R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Davidsson+P%22">Davidsson P</searchLink>; Translational Science and Experimental Medicine; Research and early Development, Cardiovascular, Renal and Metabolism, Biopharmaceutical R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Kumar+C%22">Kumar C</searchLink>; Translational Science and Experimental Medicine; Research and early Development, Cardiovascular, Renal and Metabolism, Biopharmaceutical R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Ekström+M%22">Ekström M</searchLink>; Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Eriksson+MJ%22">Eriksson MJ</searchLink>; Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Lyngå+P%22">Lyngå P</searchLink>; Karolinska Institutet, Department of Clinical Science and Education, Sodersjukhuset, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Persson+B%22">Persson B</searchLink>; Uppsala University, Department of Cell and Molecular Biology, Science for Life Laboratory, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Wallén+H%22">Wallén H</searchLink>; Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Gan+LM%22">Gan LM</searchLink>; Early Clinical Development, Research and early Development, Cardiovascular, Renal and Metabolism, Biopharmaceutical R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Persson+H%22">Persson H</searchLink>; Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Linde+C%22">Linde C</searchLink>; Karolinska Institutet, Department of Medicine, Cardiology unit, Stockholm, Sweden. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229442138%22">Journal of cardiac failure</searchLink> [J Card Fail] 2020 Dec; Vol. 26 (12), pp. 1050-1059. <i>Date of Electronic Publication: </i>2020 Aug 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Churchill+Livingstone%22">Churchill Livingstone </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9442138 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-8414 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210719164%22">10719164 </searchLink><i>NLM ISO Abbreviation: </i>J Card Fail <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32750486 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.cardfail.2020.07.010 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1050 Titles: – TitleFull: Metabolomic Profile in HFpEF vs HFrEF Patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hage C – PersonEntity: Name: NameFull: Löfgren L – PersonEntity: Name: NameFull: Michopoulos F – PersonEntity: Name: NameFull: Nilsson R – PersonEntity: Name: NameFull: Davidsson P – PersonEntity: Name: NameFull: Kumar C – PersonEntity: Name: NameFull: Ekström M – PersonEntity: Name: NameFull: Eriksson MJ – PersonEntity: Name: NameFull: Lyngå P – PersonEntity: Name: NameFull: Persson B – PersonEntity: Name: NameFull: Wallén H – PersonEntity: Name: NameFull: Gan LM – PersonEntity: Name: NameFull: Persson H – PersonEntity: Name: NameFull: Linde C IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2020 Dec Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1532-8414 Numbering: – Type: volume Value: 26 – Type: issue Value: 12 Titles: – TitleFull: Journal of cardiac failure Type: main |
| ResultId | 1 |
